Crossmark Global Holdings Inc. Takes $243,000 Position in Amedisys, Inc. (NASDAQ:AMED)

Crossmark Global Holdings Inc. purchased a new position in Amedisys, Inc. (NASDAQ:AMED) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,514 shares of the health services provider’s stock, valued at approximately $243,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State of Alaska Department of Revenue grew its holdings in Amedisys by 7.2% in the third quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider’s stock worth $365,000 after purchasing an additional 255 shares during the period. Signaturefd LLC grew its stake in shares of Amedisys by 20.9% in the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock worth $132,000 after buying an additional 236 shares during the last quarter. Creative Planning increased its position in Amedisys by 12.6% during the 3rd quarter. Creative Planning now owns 4,838 shares of the health services provider’s stock valued at $467,000 after buying an additional 543 shares in the last quarter. Exchange Traded Concepts LLC raised its stake in Amedisys by 6.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,508 shares of the health services provider’s stock valued at $725,000 after buying an additional 450 shares during the last quarter. Finally, Inspire Investing LLC boosted its holdings in Amedisys by 11.2% in the third quarter. Inspire Investing LLC now owns 4,250 shares of the health services provider’s stock worth $410,000 after acquiring an additional 428 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Trading Down 0.7 %

Shares of NASDAQ:AMED opened at $89.45 on Tuesday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 1 year low of $88.98 and a 1 year high of $98.95. The company has a market cap of $2.93 billion, a P/E ratio of 35.50, a PEG ratio of 1.87 and a beta of 0.78. The stock’s fifty day moving average price is $95.88 and its 200-day moving average price is $95.83.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. During the same quarter in the prior year, the company posted $0.98 EPS. Amedisys’s revenue was up 5.7% on a year-over-year basis. Sell-side analysts expect that Amedisys, Inc. will post 4.6 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on AMED shares. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target for the company. in a research report on Monday, July 29th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday, July 25th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $100.67.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.